http://www.law360.com/ Latest articles for organization: Johnson & Johnson Copyright 2009 Portfolio Media, Inc. en-US http://www.law360.com/images/headings/logo.gif http://www.law360.com/ http://www.law360.com/articles/132584 A federal judge has upheld a jury verdict awarding Johnson & Johnson subsidiary Centocor Ortho Biotech Inc. and New York University a record $1.67 billion for their claims that Abbott Laboratories' flagship arthritis drug Humira infringed their patent. http://www.law360.com/articles/132584 http://www.law360.com/articles/132544 The U.S. Department of Justice has named Leonard Grunstein, head of two real estate practice groups at Troutman Sanders LLP, as a defendant in a civil complaint in the still-unfolding case involving nursing home drug supply giant Omnicare Inc., which agreed Tuesday to pay $98 million to settle claims that it was part of a broad kickback scheme. http://www.law360.com/articles/132544 http://www.law360.com/articles/132433 While the verdict officially remains under wraps, word is spreading that a Pennsylvania jury has ordered Pfizer Inc. to fork over $75 million in punitive damages to a woman who developed invasive breast cancer after she began taking the popular menopause drug Prempro. http://www.law360.com/articles/132433 http://www.law360.com/articles/132248 The U.S. Department of Commerce is lauding the White House's recent pick of Suresh Kumar to the post of director general of the U.S. and Foreign Commercial Service. http://www.law360.com/articles/132248 http://www.law360.com/articles/131855 The recent decisions in Perry v. Novartis and Zandi v. Wyeth signify a trend toward courts excluding unreliable expert witness testimony based on differential diagnosis in toxic tort cases. More significantly, the cases articulate the inherent unreliability of differential diagnosis analysis when an alleged injury likely arises from unknown causes, say Kimberly Beck, K.C. Green and Gabrielle Hils of Dinsmore & Shohl LLP. http://www.law360.com/articles/131855 http://www.law360.com/articles/130699 Once on its way to becoming a deal structure relic, the friendly tender offer is back in vogue, with deal makers increasingly dusting off the strategy and becoming reacquainted with its particular charms as well as its potential complications. http://www.law360.com/articles/130699 http://www.law360.com/articles/132144 Nursing home pharmacy giant Omnicare Inc. has agreed to shell out $98 million and a Teva Pharmaceutical Industries Ltd. unit has agreed to pay $14 million to settle claims that they were part of a wide-scale kickback conspiracy. http://www.law360.com/articles/132144 http://www.law360.com/articles/131900 Following a mistrial, the U.S. Securities and Exchange Commission has dropped a suit against the head of a medical device company accused of trading on inside knowledge of Johnson & Johnson’s acquisition of diabetes products manufacturer Animas Corp. http://www.law360.com/articles/131900 http://www.law360.com/articles/131010 A British charitable trust has slapped Amgen Inc. and Pfizer Inc. subsidiary Wyeth with a lawsuit over the lucrative rheumatoid arthritis drug Enbrel, accusing the two defendants — which co-market Enbrel in the U.S. — of willfully infringing a single patent and ignoring demands for royalty payments. http://www.law360.com/articles/131010 http://www.law360.com/articles/130534 Another defendant has settled with Johnson & Johnson in a sprawling trademark case accusing more than 100 companies and individuals of participating in a scheme to sell counterfeit boxes of J&J's LifeScan OneTouch blood glucose test strips. http://www.law360.com/articles/130534 http://www.law360.com/articles/130536 In a one-two punch to Pfizer Inc., a Philadelphia jury has reportedly awarded punitive damages in addition to $3.7 million in compensatory damages to a woman who developed invasive breast cancer after she began taking Prempro, which is made by the company’s Wyeth unit. http://www.law360.com/articles/130536 http://www.law360.com/articles/130360 Wyeth Inc. and Cordis Corp. have asked a judge to dismiss or transfer a declaratory judgment suit filed by Boston Scientific Corp. in a fight over a patent related to drug coatings in stents, saying a suit they filed earlier elsewhere should take precedence. http://www.law360.com/articles/130360 http://www.law360.com/articles/129650 Guidant Corp. has prevailed in a challenge by investors to the dismissal of a putative securities class action that alleged the medical device maker glossed over problems with its defibrillators and their impact on its aborted merger with Johnson & Johnson, leading to billions of dollars in shareholder losses. http://www.law360.com/articles/129650 http://www.law360.com/articles/129135 Mylan Inc. and several other pharmaceutical companies will pay a combined sum of $124 million to settle allegations that they bilked state Medicaid programs of millions of dollars by improperly classifying certain drugs for rebate purposes. http://www.law360.com/articles/129135 http://www.law360.com/articles/128494 CIBA Vision Corp. has asked for a permanent injunction barring rival Johnson & Johnson Vision Care Inc. from selling its Acuvue Oasys With Hydraclear Plus silicone hydrogel contact lenses, on the heels of a bench trial ruling that confirmed the enforceability of CIBA's extended-wear contact lens patents. http://www.law360.com/articles/128494 http://www.law360.com/articles/128127 Stiefel Research Australia Pty Ltd., a subsidiary of skin care pharmaceutical company Stiefel Laboratories, has sued health care supplier Perrigo Co. and an Israeli subsidiary, alleging Perrigo's abbreviated new drug application for a generic male hair care product infringes Stiefel's patent governing the composition of Men's Rogaine. http://www.law360.com/articles/128127 http://www.law360.com/articles/126818 Pharmaceutical giant Pfizer Inc. has hit German drugmaker Sandoz Inc. with a patent infringement suit alleging that Sandoz's abbreviated new drug application for a generic blood pressure and cholesterol reducer rips off the patented formula for Pfizer's Caduet. http://www.law360.com/articles/126818 http://www.law360.com/articles/126727 European Commission officials raided several major drug manufacturers on Tuesday, reportedly including Sanofi-Aventis SA, as part of an investigation into anti-competitive practices. http://www.law360.com/articles/126727 http://www.law360.com/articles/126076 Cordis Corp.'s and Boston Scientific Corp.'s opposing willfulness and damages claims over three patents that remain at issue in the firms' decade-long infringement battle over stent technology will be heard in separate trials by different juries, a judge has ruled, following a landmark $716 million settlement resolving more than a dozen of the companies' lawsuits. http://www.law360.com/articles/126076 http://www.law360.com/articles/125307 Following more than a decade of litigation, Boston Scientific Corp. has agreed to fork over a whopping $716 million to Johnson & Johnson unit Cordis Corp. to settle more than a dozen lawsuits over stent technology. http://www.law360.com/articles/125307